The high accuracy of the ISET-CTC test combined with the 97% sensitivity and 99% specificity of the PSA-marker presence on prostate cancer cells, suggests an estimated positive predictive value (PPV) of 99% and a negative predictive value (NPV) of 97% for this novel screening test. The gene discussed is KLK3; the disease is prostate cancer.